US Pharma MarketingExclusive: Obesity care startup Ilant Health raises $15M
Ilant Health has raised a $15M Series A funding round to expand its personalized approach to treating obesity. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies…
Ilant Health has raised $15 million in a Series A funding round to expand its personalized approach to treating obesity.
Ilant is one of many virtual care companies competing to help employers and health plans ...
Source: Endpoints News